Women's Health

New MRI Contrast Agent Can Tell Aggressive Breast Cancer From Other Types

Can it be made cheaper and at a larger scale?

That was the end of the study, but Lu’s plans are not yet over.

Lu and his team, now that they have found a safe and effective contrasting agent that helps doctors to identify the aggressiveness of the breast cancer, are going to look into ways to make the molecule in question more cheaply and at a larger scale.

ZD2 synthesis and the formation of the fullerene ball around the gadolinium is labor-intensive, so they will have to find a way to make it easier to manufacture before this particular contrasting agent will be able to be tested on humans.